Literature DB >> 18159388

Economic analysis of rotavirus-associated diarrhea in the metropolitan Toronto and Peel regions of Ontario.

P Jacobs1, Lg Shane, K Fassbender, El Wang, R Moineddin, El Ford-Jones.   

Abstract

OBJECTIVE: To measure the economic cost of rotavirus-associated diarrhea for a selected group of families, in a nonexperimental setting, and to estimate the factors that influence these costs.
DESIGN: Use and other socioeconomic data from a family survey (the Pediatric Rotavirus Epidemiology Study for Immunization) of children who tested positive for rotavirus were collected for the metropolitan Toronto and Peel regions of Ontario during the rotavirus season of 1997-1998. Service costs were estimated from provider data. A statistical regression analysis was used to explain the variances of provincial health care costs, prescription drug costs and indirect (work-loss) costs.
SETTING: Data were collected in hospitals, emergency rooms, paediatric practices, primary care clinics and licensed daycare centres. Hospital coverage was wide, but community coverage was not. PATIENTS AND OTHER PARTICIPANTS: Children with diarrhea were tested for rotavirus. Those who tested positive and whose parents consented for their children to participate were included in the study.
INTERVENTIONS: None MAIN OUTCOME MEASURES: The main outcomes were provincial health care costs, drug costs, nonmedical costs and the number of days of work missed by parents per child, as well as factors that determine these costs.
RESULTS: Children in the most severe category incurred costs of $2,663/person, and those in the least severe categories incurred costs of approximately $350/person. The most important determinant to explain provincial health care costs was the number of health problems that the child had before having rotavirus. Costs due to work loss of parents were considerable for children in all severity groups and were influenced by family working conditions.
CONCLUSIONS: When considering the economic implications of rotavirus, prior health status should be considered and indirect costs should be recognized for their importance.

Entities:  

Keywords:  Cost; Cost analysis; Rotavirus

Year:  2002        PMID: 18159388      PMCID: PMC2094866          DOI: 10.1155/2002/926349

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  7 in total

1.  Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization.

Authors:  E L Ford-Jones; E Wang; M Petric; P Corey; R Moineddin; M Fearon
Journal:  Arch Pediatr Adolesc Med       Date:  2000-06

2.  Rotavirus-associated diarrhea in outpatient settings and child care centers. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization.

Authors:  E L Ford-Jones; E Wang; M Petric; P Corey; R Moineddin; M Fearon
Journal:  Arch Pediatr Adolesc Med       Date:  2000-06

3.  Etiology of community-acquired pediatric viral diarrhea: a prospective longitudinal study in hospitals, emergency departments, pediatric practices and child care centers during the winter rotavirus outbreak, 1997 to 1998. The Pediatric Rotavirus Epidemiology Study for Immunization Study Group.

Authors:  V Waters; E L Ford-Jones; M Petric; M Fearon; P Corey; R Moineddein
Journal:  Pediatr Infect Dis J       Date:  2000-09       Impact factor: 2.129

4.  Economic impact of immunization against rotavirus gastroenteritis. Evidence from a clinical trial.

Authors:  R I Griffiths; G F Anderson; N R Powe; E Oliveras; R J Herbert; C C Grant; B L Davidson
Journal:  Arch Pediatr Adolesc Med       Date:  1995-04

5.  Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine.

Authors:  A K Takala; E Koskenniemi; J Joensuu; M Mäkelä; T Vesikari
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

6.  Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink Team.

Authors:  U D Parashar; R C Holman; J S Bresee; M J Clarke; P H Rhodes; R L Davis; R S Thompson; J P Mullooly; S B Black; H R Shinefield; S M Marcy; C M Vadheim; J I Ward; R T Chen; R I Glass
Journal:  Pediatr Infect Dis J       Date:  1998-07       Impact factor: 2.129

7.  Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes.

Authors:  T Ruuska; T Vesikari
Journal:  Scand J Infect Dis       Date:  1990
  7 in total
  13 in total

1.  Effectiveness of rotavirus vaccine in preventing severe acute gastroenteritis in children.

Authors:  Ran D Goldman
Journal:  Can Fam Physician       Date:  2012-03       Impact factor: 3.275

2.  Literature Review on Rotavirus: Disease and Vaccine Characteristics: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  E L Ford-Jones; S Calvin
Journal:  Can Commun Dis Rep       Date:  2010-11-30

3.  Recommendations for the use of rotavirus vaccines in infants.

Authors:  M Salvadori; N Le Saux
Journal:  Paediatr Child Health       Date:  2010-10       Impact factor: 2.253

4.  Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study.

Authors:  Martin Sénécal; Marc Brisson; Marc H Lebel; John Yaremko; Richard Wong; Lee Ann Gallant; Hartley A Garfield; Darryl J Ableman; Richard L Ward; John S Sampalis; James A Mansi
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-11       Impact factor: 2.471

5.  Cost effectiveness of infant vaccination for rotavirus in Canada.

Authors:  Doug Coyle; Kathryn Coyle; Julie A Bettinger; Scott A Halperin; Wendy Vaudry; David W Scheifele; Nicole Le Saux
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

6.  Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study.

Authors:  Filippo Festini; Priscilla Cocchi; Daniela Mambretti; Bruna Tagliabue; Milena Carotti; Daniele Ciofi; Klaus P Biermann; Roberto Schiatti; Franco M Ruggeri; Fernando Maria De Benedictis; Alessandro Plebani; Alfredo Guarino; Maurizio de Martino
Journal:  BMC Infect Dis       Date:  2010-08-09       Impact factor: 3.090

7.  Current knowledge, attitude and behaviour of hand and food hygiene in a developed residential community of Singapore: a cross-sectional survey.

Authors:  Junxiong Pang; Shao Wei Jonathan Lumen Chua; Liyang Hsu
Journal:  BMC Public Health       Date:  2015-06-21       Impact factor: 3.295

8.  Physician perspectives on vaccination and diagnostic testing in children with gastroenteritis: A primary care physician survey.

Authors:  Arissa J Sperou; James A Dickinson; Bonita Lee; Marie Louie; Xiao-Li Pang; Linda Chui; Otto G Vanderkooi; Stephen B Freedman
Journal:  Paediatr Child Health       Date:  2017-06-17       Impact factor: 2.253

9.  Molecular characterization of rotavirus isolates from select Canadian pediatric hospitals.

Authors:  Andrew McDermid; Nicole Le Saux; Elsie Grudeski; Julie A Bettinger; Kathy Manguiat; Scott A Halperin; Lily Macdonald; Pierre Déry; Joanne Embree; Wendy Vaudry; Timothy F Booth
Journal:  BMC Infect Dis       Date:  2012-11-15       Impact factor: 3.090

10.  Nosocomial rotavirus gastroenterocolitis in a large tertiary paediatric hospital in Warsaw, 2006-2010.

Authors:  Aneta Nitsch-Osuch; Ernest Kuchar; Anna Kosmala; Katarzyna Zycinska; Kazimierz Wardyn
Journal:  Arch Med Sci       Date:  2013-02-10       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.